Mia's Feed
Medical News & Research

Genetic Variants Associated with Increased Risk of Bipolar Disorder

Genetic Variants Associated with Increased Risk of Bipolar Disorder

Share this article

New genetic research uncovers specific variants that significantly increase the risk of developing bipolar disorder, paving the way for personalized treatments and better understanding of the condition's genetic basis.

2 min read

Recent research has advanced our understanding of the genetic factors contributing to bipolar disorder, a complex mental health condition characterized by extreme mood swings, including depressive and manic episodes. While previous genome-wide association studies (GWAS) identified numerous genomic regions linked to bipolar disorder, pinpointing the exact causal genetic variants remained a challenge. In a groundbreaking study published in Nature Neuroscience, scientists from the Icahn School of Medicine at Mount Sinai used refined fine-mapping techniques to identify specific single nucleotide polymorphisms (SNPs) that directly influence the disorder's risk.

The study analyzed genetic data from the Psychiatric Genomics Consortium (PGC), which includes thousands of individuals of European ancestry diagnosed with bipolar disorder and healthy controls. Applying advanced statistical methods and integrating epigenomic data related to brain cell types, the researchers narrowed down the genomic regions to 17 SNPs most likely involved in increasing bipolar disorder susceptibility.

Among the identified genetic variants, the team linked these SNPs to genes involved in brain development, neurocommunication, and synaptic signaling, such as SCN2A, TRANK1, CACNA1B, THSD7A, and FURIN. Notably, some of these genes also show high expression in gut cells, suggesting a potential connection between the microbiota–gut–brain axis and bipolar disorder.

This work enhances our understanding of the genetic architecture underlying bipolar disorder and offers promising avenues for future research. The integration of these genetic findings into polygenic risk scores improves prediction accuracy across diverse populations, bringing us closer to personalized healthcare approaches. Future studies aim to functionally validate these genetic variants using models like CRISPR-edited neuronal cells and brain organoids, ultimately paving the way for tailored therapeutic strategies based on individual genetic profiles.

This research marks a significant step forward in unraveling the complex genetic factors of bipolar disorder and highlights the importance of continued exploration into the genetic and biological underpinnings of psychiatric conditions.

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Innovative Technology Decodes Immune Cell Communication to Personalize Cancer Treatment

A groundbreaking technology enables detailed mapping of immune cell interactions, paving the way for personalized cancer therapies and improved immunotherapy outcomes. Discover how this innovation enhances understanding of immune responses in infections and cancer.

Innovative LED Hyperspectral Imaging System Promises Enhanced Cancer Detection During Endoscopy

A groundbreaking LED-based hyperspectral imaging system promises to enhance real-time cancer detection during endoscopy, potentially reducing missed tumors and improving diagnosis accuracy.

Enhancing Gait Analysis with Synthetic Data: AI Models Trained on Simulated Movements Match Real-World Performance

Scientists have developed AI models for gait analysis trained exclusively on synthetic data generated through physics-based simulations. These models match or surpass traditional approaches, offering scalable solutions for diagnosing neurological and musculoskeletal disorders across diverse populations.